| SYK |
SYK: Tyrosine-protein kinase SYK |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
10.480 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
10.480 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
10.480 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
10.480 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
10.480 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
STMN2 |
STMN2, SCG10, SCGN10: Stathmin-2 |
10.480 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
PRKD1 |
PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 |
10.480 |
Evidence |
|
| CEBPB |
CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
10.480 |
Evidence |
|
| PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
10.480 |
Evidence |
|
| DAB1 |
DAB1: Disabled homolog 1 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
10.480 |
Evidence |
|
| DAB1 |
DAB1: Disabled homolog 1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
10.480 |
Evidence |
|
| WASPIP |
IPI00552369 |
PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
10.480 |
Evidence |
|
| ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
CCNB1 |
Cyclin B1 |
10.450 |
Evidence |
|
| TIAL1 |
TIAL1: Nucleolysin TIAR |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
10.450 |
Evidence |
|
| C8A |
C8A: Complement component C8 alpha chain precursor |
CFP |
CFP, PFC: Properdin precursor |
10.430 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
10.430 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
IGFBP5 |
IGFBP5, IBP5: Insulin-like growth factor-binding protein 5 precursor |
10.430 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
TACSTD1 |
TACSTD1, GA733-2, M1S2, M4S1, MIC18, TROP1: Tumor-associated calcium signal tran |
10.430 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
PRG2 |
PRG2, MBP: Bone marrow proteoglycan precursor |
10.430 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
CTSG |
CTSG: Cathepsin G precursor |
10.430 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
ELA2 |
ELA2: Leukocyte elastase precursor |
10.430 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
10.430 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
THBD |
THBD, THRM: Thrombomodulin precursor |
10.430 |
Evidence |
O
|
| SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
PROC |
PROC: Vitamin K-dependent protein C precursor |
10.430 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
10.430 |
Evidence |
|